The Association's global and regional steering committees bring together industry experts to focus on important issues relating to the quality, safety and efficacy of plasmatherapeutics.
Known technically as "oxygen therapeutics," they aim to replace only oxygen-bearing red cells rather than whole blood with its additional plasma, platelets and infection-fighting white cells.
The plasma Protein therapeutics Association (PPTA) is the primary advocate for the world's leading source plasma collectors and producers of plasma-derived and recombinant biological therapeutics.